Resumen
Definición
Anamnesis y examen
Principales factores de diagnóstico
- movement of one side of the body or one specific body part
- premonitory sensation or experience (fear, epigastric sensation, déjà vu, jamais vu)
- automatisms (picking at clothes, smacking of the lips)
- temporary aphasia
- staring and being unaware of surroundings
Otros factores de diagnóstico
- postictal focal neurological deficit (Todd paralysis, aphasia)
- persistent focal neurological deficit
- poor memory
- stigmata of neurocutaneous syndromes
Factores de riesgo
- febrile seizure
- traumatic brain injury
- central nervous system (CNS) infection
- stroke
- brain tumor
- intellectual disability and/or cerebral palsy
- dementia
- family history of seizures
- intracranial vascular malformations
- malformations of cortical development (MCDs)
- male sex
Pruebas diagnósticas
Primeras pruebas diagnósticas para solicitar
- blood glucose
- CBC
- electrolyte panel
- toxicology screen
- lumbar puncture and cerebrospinal fluid analysis
- CT head
- MRI brain
- electroencephalogram (EEG)
Pruebas diagnósticas que deben considerarse
- video/electroencephalogram (EEG) long-term monitoring (LTM)
- PET scan
- single photon emission computed tomography (SPECT) scan
- functional MRI scan
- magnetoencephalography (MEG) scan
- neuropsychological testing
- Wada test
Pruebas emergentes
- 7T MRI scan
Algoritmo de tratamiento
acute repetitive seizures: in the community
acute repetitive seizures: in the hospital
adults <60 years old: nonpregnant or no risk of pregnancy
adults ≥60 years old
women of childbearing potential
pregnant
children
Colaboradores
Autores
Ramses Ribot, MD
Assistant Professor of Clinical Neurology
Department of Neurology, Epilepsy Division
University of Miami, Miller School of Medicine
Miami
FL
Divulgaciones
RR declares that he has no competing interests.
Andres M. Kanner, MD, FANA, FAES, FAAN
Professor of Clinical Neurology
Director, Comprehensive Epilepsy Center and Head, Section of Epilepsy
Department of Neurology
University of Miami, Miller School of Medicine
Miami
FL
Divulgaciones
AMK has received honoraria from Eisai Laboratories for lectures given at international scientific meetings, and from the Epilepsy Foundation of America for being Co-Editor in Chief of Epilepsy.com. AMK is an author of a number of references cited in this topic.
Agradecimientos
Dr Ramses Ribot and Dr Andres M. Kanner would like to gratefully acknowledge Dr Vikram R. Rao, Dr John D. Hixson, and Dr Jeffrey Cohen, previous contributors to this topic.
Divulgaciones
VRR served as a paid consultant for Neuropace, Inc., manufacturer of the Responsive Neurostimulation (RNS) System. JDH has received research funding and consultancy funds from UCB, Inc. JC declares that he has no competing interests.
Revisores por pares
Edward Bromfield, MD
Chief
Epilepsy Division
Brigham and Women's Hospital
Associate Professor of Neurology
Harvard Medical School
Boston
MA
Divulgaciones
At the time of review, EB declared that between 2004 and 2009, he received speaking honoraria from UCB Pharma, Novartis, Abbott Laboratories, GlaxoSmithKline, and Pfizer. He received consulting fees from UCB Pharma, Genzyme, and Spherics, and research funding from UCB Pharma. Unfortunately, we have since been made aware that EB is deceased.
Angus A. Wilfong, MD
Associate Professor
Pediatrics and Neurology
Baylor College of Medicine
Medical Director
Comprehensive Epilepsy Program
Texas Children's Hospital
Houston
TX
Divulgaciones
AAW declares that he has no competing interests.
Cigdem I. Akman, MD
Assistant Professor
Division of Pediatric Neurology
Columbia University College of Physicians and Surgeons
New York
NY
Divulgaciones
Not disclosed.
Pasquale Striano, MD, PhD
Consultant Neurologist
Muscular and Neurodegenerative Diseases Unit
"G Gaslini" Institute
Genova
Epilepsy Centre
Federico II University
Napoli
Italy
Divulgaciones
PS declares that he has no competing interests.
Agradecimiento de los revisores por pares
Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.
Divulgaciones
Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.
Referencias
Artículos principales
Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017 Apr;58(4):522-30.Texto completo Resumen
Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017 Apr;58(4):512-21.Texto completo Resumen
Leone MA, Giussani G, Nevitt SJ, et al. Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure. Cochrane Database Syst Rev. 2021 May 4;(5):CD007144.Texto completo Resumen
American Academy of Neurology. Update: efficacy and tolerability of the new antiepileptic drugs I: treatment of new-onset epilepsy. Jun 2018 [internet publication].Texto completo Resumen
American Academy of Neurology. Update: efficacy and tolerability of the new antiepileptic drugs II: treatment-resistant epilepsy. Jun 2018 [internet publication].Texto completo
Nevitt SJ, Sudell M, Cividini S, et al. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. Cochrane Database Syst Rev. 2022 Apr 1;4(4):CD011412.Texto completo Resumen
Artículos de referencia
Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
Diferenciales
- Syncope
- Transient ischemic attack (TIA)
- Sleep disorders
Más DiferencialesGuías de práctica clínica
- Epilepsies in children, young people and adults
- Antiseizure medication withdrawal in seizure-free patients: practice advisory update summary
Más Guías de práctica clínicaFolletos para el paciente
Epilepsy: what is it?
Epilepsy: what are the treatment options?
Más Folletos para el pacienteInicie sesión o suscríbase para acceder a todo el BMJ Best Practice
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad